financetom
Business
financetom
/
Business
/
Avinger Prices Public Offering of Shares, Series Warrants
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Avinger Prices Public Offering of Shares, Series Warrants
Jun 14, 2024 8:31 AM

11:13 AM EDT, 06/14/2024 (MT Newswires) -- Avinger (AVGR) said Friday it has priced its public offering of about 3.6 million shares and Series Warrants at a combined price of $1.66 per share and accompanying warrants.

The offering is expected to raise $6 million upfront for the company, with up to an additional $18 million upon the exercise in full of clinical milestone-linked A-1, A-2 and A-3 Series Warrants, the medical device company said.

The firm said it plans to use the net proceeds for working capital and general corporate purposes.

The offering will close on or about Monday, with H.C. Wainwright as the placement agent, Avinger said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Correction: Lexicon Pharmaceuticals Plans Job Cuts as Part of Cost-Cutting Measures
Correction: Lexicon Pharmaceuticals Plans Job Cuts as Part of Cost-Cutting Measures
Aug 13, 2024
09:42 AM EDT, 08/13/2024 (MT Newswires) -- (Corrects first paragraph to accurately reflect approximate number of job cuts) Lexicon Pharmaceuticals ( LXRX ) said Tuesday it is planning to cut more than 75, or approximately 50% of its current workforce, by the end of Q3 as part of its cost-cutting measures. Under the measures, the company will reallocate resources for...
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
Aug 13, 2024
Syros Pharmaceuticals Inc. ( SYRS ) stock is trading lower on Tuesday after the company issued an update on the SELECT-AML-1 Phase 2 trial. The company announced that it will discontinue enrollment in the SELECT-AML-1 Phase 2 trial evaluating the triplet regimen of tamibarotene in combination with venetoclax and azacitidine compared to the doublet regimen of venetoclax and azacitidine in newly...
MGM Resorts International Pick of the Week at Smart Insider Following Stock Purchases of Chair, CEO, CFO
MGM Resorts International Pick of the Week at Smart Insider Following Stock Purchases of Chair, CEO, CFO
Aug 13, 2024
09:42 AM EDT, 08/13/2024 (MT Newswires) -- MGM Resorts International ( MGM ) was the stock pick of the week from Smart Insider after the company's chair, chief executive and chief financial officer bought a combined $7.3 million worth of stock at about $34 per share on Aug. 5. Chair Paul Salem increased his holding in the company by 9%...
Alaska Air Group Makes Investment in JetZero
Alaska Air Group Makes Investment in JetZero
Aug 13, 2024
09:43 AM EDT, 08/13/2024 (MT Newswires) -- Alaska Air Group ( ALK ) said Tuesday that it had made an investment in JetZero, a pioneering company developing a new blended-wing body aircraft that might reduce fuel consumption. The amount of the investment was not disclosed. Alaska said it invested as part of JetZero's series A last year. The airline said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved